Relapse Multiple Myeloma: Clinical Trials

1 trial for Relapse Multiple Myeloma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow Relapse Multiple Myeloma: new trials by email Literature Review of Relapse Multiple Myeloma trials Research Report on Relapse Multiple Myeloma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma
Dual CD19/BCMA CAR-T - Relapse Multiple Myeloma
Not applicableRecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine252025-11-012026-01-22

Sponsors

Second Affiliated Hospital, Zhejiang University, School of Medicine (1)

Countries

China (1)

Top investigators

Wenbin Qian, Dr. (1)